Skip to main content
. 2017 Sep 23;216(11):1362–1370. doi: 10.1093/infdis/jix503

Figure 1.

Figure 1.

Disposition of subjects (as treated; 1 subject who was randomly assigned to receive respiratory syncytial virus (RSV) vaccine received placebo in error). IIV, inactivated influenza vaccine; PI, principal investigator. aCompleted efficacy follow-up.